Jonathan Poole
Equibles does not estimate personal net worth.
Get an email with a short summary when Vertex Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get VRTX alertsAbout Jonathan Poole
Jonathan Poole is recorded as CFO at Vertex Pharmaceuticals Inc (VRTX) since January 1, 2027. Vertex Pharmaceuticals Inc reported in an 8-K filed September 1, 2026 that Jonathan Poole was appointed Executive Vice President and Chief Financial Officer, effective January 1, 2027. Vertex Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vertex Pharmaceuticals Inc includes Dr. Reshma Kewalramani (CEO), Reshma Kewalramani (CEO and Board Member), Dr. Jeffrey M. Leiden (Chairman) and 7 others.
“On August 27, 2026, Vertex Pharmaceuticals Incorporated (the “Company”) appointed Jonathan Poole as Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2027 (the “Effective Date”).”
Affiliation history
-
Current
2027-01-01–present
Company network
Leadership on record at Vertex Pharmaceuticals Inc
- Dr. Reshma Kewalramani CEO
- Reshma Kewalramani CEO, Board Member
- Dr. Jeffrey M. Leiden Chairman
- Jeffrey Leiden Chairman, Board Member
- Charles Wagner CFO
- Charles F. Wagner, Jr. COO
- Alan Garber Board Member
- Bruce Sachs Board Member
- Daniel Brennan Board Member
- Diana McKenzie Board Member